Scientists test antidepressants for treatment of COVID-19
Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI), is for the treatment of obsessive compulsive disorder and depression, among other disorders.
Fluvoxamine sold under the brand name Luvox(photo credit: Wikimedia Commons)ByZACHARY KEYSER
